» Articles » PMID: 20495104

Quality of Life in Long-term Survivors of Acute Pulmonary Embolism

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2010 May 25
PMID 20495104
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To our knowledge, studies evaluating the quality of life (QoL) in patients with a history of acute pulmonary embolism (PE) are not available, even though QoL is a key outcome component of medical care and a predictor of disease-specific prognosis.

Methods: As part of a large follow-up study, the Short Form 36 (SF-36) was presented to consecutive patients who had survived one or more episodes of acute PE. The results of all nine subscales of the SF-36 were compared with sex- and age-adjusted Dutch population norms. Single and multivariate analyses were performed to identify independent determinants of the QoL in our study population.

Results: The SF-36 was completed by 392 patients. Except for the health change subscale, patients had substantially lower QoL than population norms on all eight remaining subscales. After multivariate analysis, the time interval between the last thromboembolic episode and study inclusion was inversely related to QoL, and significant determinants of poor QoL were prior PE, age, obesity, active malignancy, and cardiopulmonary comorbid conditions. Regression models that included all identified significant determinants proved to be quite modest predictors for QoL in the individual patient. Awareness of illness, coping mechanisms, and self-management behavior might be additional important indicators of QoL in our study population but require further investigation.

Conclusion: We identified several PE- and non-PE-related determinants of QoL in patients with a history of acute PE, which is impaired compared with sex- and age-adjusted population norms. QoL after acute PE should be studied more extensively and added as a standard measure to outcome studies.

Citing Articles

Effect of exercise on physical fitness and quality of life in patients with pulmonary embolism: a systematic review and meta-analysis.

Chen M, Wang Y, Zhou T, He J, Zhang M, Yan Z J Thorac Dis. 2024; 16(11):7350-7360.

PMID: 39678880 PMC: 11635206. DOI: 10.21037/jtd-24-1017.


Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.

Sista A, Troxel A, Tarpey T, Parpia S, Goldhaber S, Stringer W Am Heart J. 2024; 281:112-122.

PMID: 39638275 PMC: 11810573. DOI: 10.1016/j.ahj.2024.11.016.


Venous Thromboembolism: Current Insights and Future Directions.

Mahani S, DiCaro M, Tak N, Hartnett S, Cyrus T, Tak T Int J Angiol. 2024; 33(4):250-261.

PMID: 39502354 PMC: 11534468. DOI: 10.1055/s-0044-1787652.


Quality of life in oncological patients with venous thromboembolic disease.

Arteaga A, Font C, Rojas Hernandez C Res Pract Thromb Haemost. 2024; 8(5):102510.

PMID: 39188888 PMC: 11347054. DOI: 10.1016/j.rpth.2024.102510.


Functional limitations 3 and 12 months after venous thromboembolism: a cohort study.

Steiner D, Nopp S, Heinze G, Kraemmer D, Schlager O, Barco S Res Pract Thromb Haemost. 2024; 8(4):102464.

PMID: 39006228 PMC: 11245970. DOI: 10.1016/j.rpth.2024.102464.